01 Dec Laminar Pharma announces that it will reach 1.2M euros with its latest round of financing
One week before closing the funding round, the company has surpassed 90% of the target figure.The funding round is managed through the Fellow Funders Crowd Investment platform and is part of the preparations prior to Laminar joining BME Growth.The company's stock market debut on BME Growth (formerly Alternative Stock...
